Pilot study to assess the efficacy of botulinum Toxin B (Myobloc) treatment of paravertebral muscles on pain and disability in subjects suffering from acute low back pain

Trial Profile

Pilot study to assess the efficacy of botulinum Toxin B (Myobloc) treatment of paravertebral muscles on pain and disability in subjects suffering from acute low back pain

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Botulinum toxin B (Primary)
  • Indications Back pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Mar 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 30 May 2007 Status changed from recruiting to initiated.
    • 21 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top